γ-Secretase-mediated regulation of seprilysin: Influence of cell density and aging and modulation by imatinib

Journal of Alzheimer's Disease

Volumn 27, Issue 3, 2011, Pages 511-520

  Bauer, Charlotte ^a   Pardossi Piquard, Raphäelle ^a   Dunys, Julie ^a   Roy, Maggie ^a   Checler, Frédéric ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

AICD; A PP null fibroblasts; cell aging; cell density; HEK293 cells; imatinib; neprilysin; PS null fibroblasts; secretase

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GAMMA SECRETASE; IMATINIB; MEMBRANE METALLOENDOPEPTIDASE; MEMBRANE PROTEIN; MESSENGER RNA; PRESENILIN 1; PRESENILIN 2; PROTEIN TYROSINE KINASE INHIBITOR;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN; CELL DENSITY; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; FIBROBLAST; FLUOROMETRY; GLIOMA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 82555195160     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110746     Document Type: Article

References (49)

1. Hardy JA, Higgins GA (1992) Alzheimer's disease: The amyloid cascade hypothesis. Science 256, 184-185.
2. Wirths O, Multhaup G, Bayer TA (2004) A modifiedβ-amyloid hypothesis: Intraneuronal accumulation of theβ- amyloid peptide-the first step of a fatal cascade. J. Neurochem 91, 513-520. (Pubitemid 39431147)
3. Checler F (1995) Processing of theβ-amyloid precursor protein and its regulation in Alzheimer's disease. J Neurochem 65, 1431-1444.
4. KimberlyWT, LaVoie MJ, Ostaszewski BL,YeW,Wolfe MS, Selkoe D (2003) β-secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1 and pen-2. Proc Natl Acad Sci U S A 100, 6382-6387. (Pubitemid 36666590)
5. Takasugi N, Tomita T, Hayashi I, Tsuruoka M, Niimura M, Takahashi Y, Thinakaran G, Iwatsubo T (2003) The role of presenilin cofactors in theβ-secretase complex. Nature 422, 438-441. (Pubitemid 36411397)
6. Edbauer D,Winkler E, Regula JT, Pesold B, Steiner H, Haass C (2003) Reconstitution ofβ-secretase activity. Nat Cell Biol 5, 486-488.
7. Apelt J, Ach K, Schliebs R (2003) Aging-related downregulation of neprilysin, a putativeβ-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity ofβ-amyloid plaques. Neurosci Lett 339, 183-186. (Pubitemid 36298997)
8. Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM (2005) Age- and region- dependent alterations in Aβ- degrading enzymes: Implications for Aβ-induced disorders. Neurobiol Aging 26, 645-654.
9. Wang S, Wang R, Chen L, Bennett DA, Dickson DW, Wang DS (2010) Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin converting enzyme in prospectively studied elderly and Alzheimer's brain. J Neurochem 115, 47-57.
10. Russo R, Borghi R, Markesbery W, Tabaton M, Piccini A (2005) Neprylisin decreases uniformly in Alzheimer's disease and in normal aging. FEBS Lett 579, 6027-6030. (Pubitemid 41546241)
11. Hellstrom-Lindahl E, Ravid R, Nordberg A (2006) Agedependent decline of neprilysin in Alzheimer's disease and normal brain: Inverse correlation with Abeta levels. Neurobiol Aging 29, 210-221.
12. Passer B, Pellegrini L, Russo C, Siegel RM, Lenardio MJ, Schettini G, Bachmann M, Tabaton M, D'Adamio L (2000) Generation of an apoptotic intracellular peptide byβ-secretase cleavage of Alzheimer's amyloidβ protein precursor. J Alzheimers Dis 2, 289-301. (Pubitemid 32095613)
13. Cao X, Südhof TC (2001) A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120. (Pubitemid 32625507)
14. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, Rosenfeld MG (2002) Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kB andβ-amyloid precursor protein. Cell 110, 55-67. (Pubitemid 34874606)
15. Kim HS, Kim EM, Lee JP, Park CH, Kim SJ, Seo JH, Chang KA, Yu E, Jeong SJ, Chong YH, Suh YH (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3b expression. FASEB J 17, 1951-1953.
16. Ryan KA, Pimplikar SW (2005) Activation of GSK3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J Cell Biol 171, 327-335. (Pubitemid 41540024)
17. von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM,KonietzkoU(2004) The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci 117, 4435-4448. (Pubitemid 39360070)
18. Alves da Costa C, Sunyach C, Pardossi-Piquard R, Sevalle J, Vincent B,Boyer N,KawaraiT, Girardot N, St George-Hyslop P, Checler F (2006) Presenilin-dependent gamma-secretasemediated control of p53-associated cell death in Alzheimer's disease. J Neurosci 26, 6377-6385.
19. Zhang YW, Wang R, Liu Q, Zhang H, Liao FF, Xu H (2007) Presenilin/gamma-secretase-dependent processing of betaamyloid precursor protein regulates EGF receptor expression. Proc Natl Acad Sci U S A 104, 10613-10618. (Pubitemid 47185713)
20. Liu Q, Zerbinatti CV, Zhang J, Hoe HS, Wang B, Cole SL, Herz J, Bu MugliaL, G (2007) Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 56, 66-78. (Pubitemid 47484175)
21. Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C,Vincent B, Ring S, D'Adamio L, Shen J, Muller U, St George Hyslop P, Checler F (2005) Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron 46, 541-554. (Pubitemid 40797380)
22. Pardossi-Piquard R, Dunys J, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, Sevalle J, Pimplikar S, St George-Hyslop P, Checler F (2007) Response to correspondence: Pardossi- Piquard et al. 'Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP'. Neuron 46, 541-554. Neuron 53, 483-486.
23. Pardossi-Piquard R, Dunys J, Yu G, St George-Hyslop P, Alves da Costa C, Checler F (2006) Neprilysin activity and expression are controlled by nicastrin. J Neurochem 97, 1052-1056.
24. Carroll RT, Lust MR, Kim KS, Doyle PD, Emmerling MR (1995) An age-related correlation between levels of beta-amyloid precursor protein and beta-amyloid in human cerebrospinal fluid. Biochem Biophys Res Commun 210, 345-349.
25. Anderson JJ, Holtz G, Baskin PP,Wang R, Mazzarelli L,Wagner SL, Menzaghi F (1999) Reduced cerebrospinal fluid levels of a-secretase-cleaved amyloid precursor protein in aged rats: Correlation with spatial memory deficits. Neuroscience 93, 1409-1420. (Pubitemid 29397570)
26. Zohar O, Pick CG, Cavallaro S, Chapman J, KatsavA, Milman A, Alkon DL (2005) Age-dependent differential expression of BACE splice variants in brain regions of Tg2576 mice. Neurobiol Aging 26, 1167-1175. (Pubitemid 40726009)
27. Nistor M, Don M, Parekh M, Sarsoza F, Goodus M, Lopez GE, Kawas C, Leverenz J, Doran E, Lott IT, Hill M, Head E (2007) Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain. Neurobiol Aging 28, 1493-1506. (Pubitemid 47238529)
28. Placanica L, Zhu L, LiYM(2009) Gender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease. PLoS ONE 4, e5088.
29. Cai Y, Xiong K, Zhang XM, Cai H, Luo XG, Feng JC, Clough RW, Struble RG, Patrylo PR, Chu Y, Kordower JH, Yan XX (2010) beta-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and beta-amyloid accumulation. Eur J Neuroscience 32, 1223-1238.
30. Dutriez I, Sales N, Fournie-Zaluski MC, Roques BP (1992) Pre- and post-natal ontogeny of neutral endopeptidase 24-11 ('enkephalinase') studied by in vitro autoradiography in the rat. Experientia 48, 290-300.
31. Milhiet PE, Beaumont A, Garbay-Jaureguiberry C, Roques BP (1992) Increase of neutral endopeptidase-24.11 with cellular density and enzyme modulation with an inhibitor on human Reh6 cell line. Biochem Pharmacol 43, 1711-1715.
32. Kletsas D, Caselgrandi E, Barbieri D, Stathakos D, Franceschi C, Ottaviani E (1998) Neutral endopeptidase-24.11 (NEP) activity in human fibroblasts during development and ageing. Mech Ageing Dev 102, 15-23 (Pubitemid 28256905)
33. Iwata N, Takaki Y, Fukami S, Tsubuki S, Saido TC (2002) Region-specific reduction of Ab-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. Neurosci Res 43, 39-56.
34. Hwang DY, Cho JS, Kim CK, Shim SB, Jee SW, Lee SH, Seo SJ, Cho JY, Kim YK (2005) Aging-related correlation of insulin-degrading enzyme with gamma-secretase-generated products involving insulin and glucose levels in transgenic mice. Neurochem. Res 30, 1171-1177. (Pubitemid 41642161)
35. Kern A, Roempp B, Prager K, Walter J, Behl C (2006) Down-regulation of endogenous amyloid precursor protein processing due to cellular aging. J Biol Chem 281, 2405-2413. (Pubitemid 43845700)
36. Franberg J, Karlstrom H,Winblad B, Tjernberg LO, Frykman S (2010) Gamma-secretase dependent production of intracellular domains is reduced in adult compared to embryonic rat brain membranes. PLoS ONE 5, e9772.
37. Chen AC, Selkoe DJ (2007) Response to: Pardossi-Piquard et al. 'Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP.' Neuron 46, 541-554. Neuron 53, 479-483.
38. Eisele YS, Baumann M, Klebl B, Nordhammer C, Jucker M, Kilger E (2007) Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloidbeta degrading enzyme neprilysin. Mol Biol Cell 18, 3591-3600. (Pubitemid 47378696)
39. Kimberly WT, Zheng JB, Guénette S, Selkoe DJ (2001) The intracellular domain of theβ-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a Notchlike manner. J Biol Chem 276, 40288-40292.
40. Kinoshita A, Whelan CM, Smith CJ, Berezovska O, Hyman BT (2002) Direct visualization of the gamma secretasegenerated carboxy-terminal domain of the amyloid precursor protein: Association with Fe65 and translocation ot the nucleus. J Neurochem 82, 839-847.
41. Konietzko U, Goodger ZV, Meyer M, Kohli BM, Bosset J, Lahiri DK, Nitsch RM (2010) Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories. Neurobiol Aging 31, 58-73.
42. Goodger ZV, Rajendran L, Trutzel A, Kohli BM, Nitsch RM, Konietzko, U (2009) Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway. J Cell Sci 122, 3703-3714.
43. Belyaev ND, Kellett KA, Beckett C, Makova NZ, Revett TJ, Nalivaeva NN, Hooper NM, Turner AJ (2010) The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway. J Biol Chem 285, 41443-41454.
44. Checler F, Sunyach C, Pardossi-Piquard R, Sevalle J, Vincent B, Kawarai T, Girardot N, St George-Hyslop P, da Costa CA (2007) The gamma/epsilon- secretase-derived APP intracellular domain fragments regulate p53. Curr Alz Res 4, 423-426. (Pubitemid 47416636)
45. Belyaev ND, Nalivaeva NN, Makova NZ, Turner AJ (2009) Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: Implications for Alzheimer disease. EMBO Rep 10, 94-100.
46. Xu X, Zhou H, Boyer TG (2011) Mediator is a transducer of amyloid-precursor-protein-dependent nuclear signalling. EMBO Rep 3, 216-222.
47. Zhang C, Browne A, Divito JR, Stevenson JA, Romano D, Dong Y, Xie Z, Tanzi RE (2010) Amyloid-beta production via cleavage of amyloid-beta protein precursor is modulated by cell density. J Alzheimers Dis 22, 683-984.
48. HongY, Beckett C, Belyaev ND,Turner AJ (2011) The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells. Int J Cancer. doi: 10.1002/ijc.26028
49. He G, LuoW, Li P, Remmers C, Netzer J, Hendrick J, Bettayeb K, Flajolet M, Gorelick F, wennogle LP, Greengard P (2010) Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease. Nature 467, 95-99.